This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. NOTV, AIKI, LUNA, ONMD, BIAF, DKDCA, ISPC, IQV, ICLR, and INCYShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), AIkido Pharma (AIKI), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). Bioanalytical Systems vs. Inotiv AIkido Pharma Luna Innovations OneMedNet bioAffinity Technologies Data Knights Acquisition iSpecimen IQVIA ICON Public Incyte Bioanalytical Systems (NASDAQ:BASI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, community ranking, analyst recommendations, profitability, earnings and media sentiment. Do insiders & institutionals believe in BASI or NOTV? 10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 18.2% of Inotiv shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by company insiders. Comparatively, 7.8% of Inotiv shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is BASI or NOTV more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Inotiv -25.40%-15.41%-3.58% Do analysts rate BASI or NOTV? Inotiv has a consensus target price of $5.92, suggesting a potential upside of 151.77%. Given Inotiv's stronger consensus rating and higher possible upside, analysts plainly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, BASI or NOTV? Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Comparatively, Inotiv has a beta of 3.96, suggesting that its share price is 296% more volatile than the S&P 500. Does the MarketBeat Community believe in BASI or NOTV? Bioanalytical Systems received 109 more outperform votes than Inotiv when rated by MarketBeat users. However, 48.72% of users gave Inotiv an outperform vote while only 36.47% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12836.47% Underperform Votes22363.53% InotivOutperform Votes1948.72% Underperform Votes2051.28% Which has better valuation & earnings, BASI or NOTV? Bioanalytical Systems has higher earnings, but lower revenue than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.43-$4.68M-$0.35-6.71Inotiv$475.11M0.17-$108.44M-$4.61-0.51 Does the media refer more to BASI or NOTV? In the previous week, Bioanalytical Systems' average media sentiment score of 0.00 equaled Inotiv'saverage media sentiment score. Company Overall Sentiment Bioanalytical Systems Neutral Inotiv Neutral SummaryInotiv beats Bioanalytical Systems on 10 of the 16 factors compared between the two stocks. Remove Ads Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.16M$3.12B$5.25B$7.12BDividend YieldN/A2.31%4.89%4.06%P/E Ratio-5.6092.9721.2317.48Price / Sales0.43103.41354.9985.32Price / Cash558.4034.5738.1834.64Price / Book3.412.396.243.79Net Income-$4.68M$113.28M$3.20B$247.48M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$2.35-14.9%N/A-61.6%$26.16M$60.47M-5.60397Analyst ForecastGap DownHigh Trading VolumeNOTVInotiv2.1913 of 5 stars$2.21+2.8%$5.92+167.7%-67.3%$74.52M$475.11M-0.482,100Gap DownAIKIAIkido PharmaN/A$4.78-8.6%N/A+46.5%$26.22M$10,000.00-1.234High Trading VolumeLUNALuna Innovations1.1829 of 5 stars$0.68-2.9%$8.00+1,076.5%-82.7%$23.09M$116.61M0.00390Analyst ForecastONMDOneMedNetN/A$0.54-3.6%N/A-47.8%$15.11M$957,651.000.002Upcoming EarningsBIAFbioAffinity Technologies1.5283 of 5 stars$0.26-0.7%$6.00+2,207.7%-73.5%$4.05M$9.37M-0.3210Earnings ReportUpcoming EarningsAnalyst ForecastNews CoverageHigh Trading VolumeDKDCAData Knights AcquisitionN/A$0.56-2.8%N/A-41.8%$2.90MN/A-2.952Gap DownISPCiSpecimen0.4957 of 5 stars$1.06-7.8%N/A+425.3%$1.02M$10.39M-0.0660Gap DownIQVIQVIA4.8065 of 5 stars$176.28-0.6%$249.05+41.3%-35.2%$31.08B$15.41B23.5086,000Positive NewsGap DownICLRICON Public4.1553 of 5 stars$174.99-2.3%$272.50+55.7%-50.9%$14.13B$8.28B18.3641,100Gap DownINCYIncyte4.6039 of 5 stars$60.55-0.1%$74.88+23.7%+10.2%$11.72B$4.24B224.272,320Positive News Remove Ads Related Companies and Tools Related Companies Inotiv Competitors AIkido Pharma Competitors Luna Innovations Competitors OneMedNet Competitors bioAffinity Technologies Competitors Data Knights Acquisition Competitors iSpecimen Competitors IQVIA Competitors ICON Public Competitors Incyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BASI Stock Free BASI Stock Alerts